Aviance Capital Partners, LLC Merck & Co., Inc. Transaction History

Aviance Capital Partners, LLC

$681 Million
Q2 2024

A detailed history of Aviance Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aviance Capital Partners, LLC holds 40,149 shares of MRK stock, worth $4.56 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

40,149

Previous 40,118 0.08%

Holding current value

$4.56 Million

Previous $5.29 Million 6.1%

% of portfolio

0.73%

Previous 0.81%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $3,837 - $4,121	31 Added 0.08%	40,149 $4.97 Million
Q1 2024 Apr 17, 2024	BUY	$113.24 - $131.95 $1.86 Million - $2.17 Million	16,466 Added 69.62%	40,118 $5.29 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $194,749 - $211,934	-1,944 Reduced 7.59%	23,652 $2.58 Million
Q3 2023 Nov 06, 2023	BUY	$102.95 - $114.33 $200,752 - $222,943	1,950 Added 8.25%	25,596 $2.64 Million
Q2 2023 Aug 04, 2023	SELL	$108.61 - $118.38 $43,444 - $47,352	-400 Reduced 1.66%	23,646 $2.73 Million
Q1 2023 May 10, 2023	BUY	$102.94 - $114.86 $213,909 - $238,679	2,078 Added 9.46%	24,046 $2.56 Million
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $101,955 - $130,720	-1,166 Reduced 5.04%	21,968 $2.44 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $4,226 - $4,748	-50 Reduced 0.22%	23,134 $1.99 Million
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $36,975 - $41,447	-503 Reduced 2.12%	23,184 $1.9 Million
Q4 2021 Feb 07, 2022	SELL	$72.28 - $90.54 $5,276 - $6,609	-73 Reduced 0.31%	23,687 $1.82 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $22,292 - $24,516	311 Added 1.33%	23,760 $1.79 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $19,124 - $21,153	272 Added 1.17%	23,449 $1.82 Million
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $14,942 - $17,600	-217 Reduced 0.93%	23,177 $1.79 Million
Q2 2020 Jul 24, 2020	SELL	$70.42 - $80.13 $14,084 - $16,026	-200 Reduced 0.85%	23,394 $1.81 Million
Q1 2020 May 05, 2020	SELL	$63.36 - $87.82 $123,742 - $171,512	-1,953 Reduced 7.64%	23,594 $1.82 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $61,598 - $69,506	-794 Reduced 3.01%	25,547 $2.32 Million
Q3 2019 Nov 07, 2019	SELL	$76.08 - $82.93 $393,637 - $429,079	-5,174 Reduced 16.42%	26,341 $2.22 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $27,237 - $31,820	390 Added 1.25%	31,515 $2.64 Million
Q1 2019 May 01, 2019	SELL	$69.58 - $79.36 $17,951 - $20,474	-258 Reduced 0.82%	31,125 $2.59 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $48,603 - $56,403	-745 Reduced 2.32%	31,383 $2.4 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $66,343 - $78,016	1,150 Added 3.71%	32,128 $2.28 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $783,493 - $920,524	15,414 Added 99.04%	30,978 $1.88 Million
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $913,139 - $982,555	15,564	15,564 $997,000

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.

Account

Aviance Capital Partners, LLC Merck & Co., Inc. Transaction History